BridgeMD
New treatment option for Non-birthing Partner Vaccination in Pregnancy
Official title Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
ClinicalTrials.gov ID: NCT06135636
What this study is testing
What is Vaccine administration?
Vaccine administration is an investigational medicine, being studied as a potential treatment for non-birthing partner vaccination in pregnancy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this randomized control trial is to assess if prenatal vaccine education and in-office vaccination administration for non-birthing partners of pregnant patients increases Tdap vaccination rates compared to usual care. The main question(s) it aims to answer are: To assess whether compared to standard prenatal care, targeted prenatal education regarding Tdap vaccination recommendations with and without in office vaccination opportunities improves Tdap uptake among non-birthing partners of pregnant patients.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 50. Healthy volunteers may be eligible.
You may be able to join if
- Partners of pregnant patients who are receiving their prenatal care at the OGCC
- 19-50 years old: This age range was selected as 19 years is both the age at which adult Tdap vaccination is recommended by the CDC as well as the age...
- Have not or are unsure if they have received the adult Tdap vaccine or booster in the last 10 years: In addition to the CDC recommendation for adult...
- Fluency in English or Spanish: Consents, surveys, and Tdap and cocooning information will be available in both languages.
You likely can't join if
- Latex allergy: Contraindication to the state supplied Tdap vaccine
- Lethal fetal anomaly diagnosed prior to enrollment to prevent undue distress with follow-up postpartum
The study team makes the final eligibility decision.
Where it's taking place
- Providence, Rhode Island, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Providence, Rhode Island, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.